Industry Outlook
The radiation dose management market is set to reach US$ 1,349.5 Mn by 2027 from US$ 179.0 Mn in 2018 projecting rapid growth at a compounded annual growth rate (CAGR) of 25.8% during the forecast period from 2019 to 2027. The major drivers associated with radiation dose management market are rising prevalence of chronic ailment and stringent regulatory norm related to safety of radiation exposure in patients. Significant rise in diagnostic screening centers and rising public health awareness further propel the radiation dose management market.
Market Synopsis
Get a sample copy for more information
"Capability to design robust radiation safety program and efficient collection of clinical data pertaining to patient disease screening increased the demand for software solutions"
In the present scenario the software solutions are spearheading the solution segment for radiation dose management market. Prominent features associated such as capability to design robust radiation safety program ensuring negligible side effects in patients exposed to radiation therapy increases the demand for software solutions. Efficient collection of clinical data pertaining to patient disease diagnosis further propels the market growth for software solutions. Services are keen to register steady growth in the near future owing to rising public health awareness resulting in early disease diagnosis and significant rise in diagnostic centers worldwide.
"Ease of operation, effective radiation dose monitoring and quick acquisition of precise images increases the popularity of computed tomography over other modalities"
Computed tomography is currently leading the modality segment for radiation dose management market. The inherent features associated with computed tomography are elimination of overlapping structures making the internal anatomy more apparent and visible. It guides the surgeons during critical surgical procedures, ease of operation, effective radiation dose monitoring and quick turnaround time are the key attributes which increase sits popularity over other modalities. Nuclear medicine scans have gained tremendous attention in the last decade owing to its capability in understanding the cellular metabolism in chronic disease, thorough investigation of tumor or infection and its spread in the body. It is a useful tool to validate whether the ongoing treatment protocol is effective or needs change.
Get a sample copy for more information
"Stringent regulatory norms regarding patient safety receiving radiation therapy and rising prevalence of chronic disease drive the market growth in North America"
North America holds the largest market share of 36% in the regional segment for radiation dose management market. The chief parameters consolidating its market growth in North America are stringent norms imposed by healthcare agencies in patients receiving radiation therapy and rising prevalence of chronic disease resulting in early disease diagnosis. Favorable reimbursement scenario pertaining to utilization of radiation dose therapy further bolsters the market growth in the region. Europe represents 29.5% market share and is the second largest regional market owing to domicile of key players such as Bayer AG, Philips Healthcare, Sectra AB etc. promote the market performance of radiation dose management. Asia Pacific with a market share of 22% is keen to register outstanding growth over the forecast period on account of developing healthcare infrastructure and increasing medical tourism.
Get a sample copy for more information
Historical & Forecast Period
This research report presents the analysis of each segment from 2017 to 2027 considering 2018 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2019 to 2027.
Report Scope by Segments
The market segmentation for the scope of report is done as by solution, modality and geography.
| ATTRIBUTE |
DETAILS |
| Research Period |
2017-2027 |
| Base Year |
2018 |
| Forecast Period |
2019-2027 |
| Historical Year |
2017 |
| Unit |
USD Million |
| Segmentation |
By Solution (2017–2027; US$ Mn)
• Software
• Services
|
|
By Indication (2017–2027; US$ Mn)
• Radiography
• Computed Tomography
• Mammography
• Fluoroscopy & Interventional Imaging
• Nuclear Medicine Scans
• Others
|
|
Geography Segment (2017–2027; US$ Mn)
• North America (U.S., Canada)
• Europe (U.K., Germany, Rest of Europe)
• Asia Pacific (China, Japan, Rest of Asia Pacific)
• Latin America (Brazil, Mexico, Rest of Latin America)
• Middle East and Africa (GCC, Rest of MEA)
|
Medical device manufacturers specializing in radiation dose management solutions are Bayer AG, Fujifilm Holdings Corporation, Bracco Imaging S.P.A., GE Healthcare, Philips Healthcare, Medsquare, Novarad Corporation, Sectra AB, Pacshealth, LLC. and Qaelum N.V.
Key questions answered in this report
- Which major medical device manufacturers are providing radiation dose management solutions?
- What are the latest acquisition and mergers taking place in the radiation dose management market?
- What are the regulatory guidelines sanctioned for the safety pertaining to radiation therapy?
- Which factors promote software solutions market growth?
- What is the principle pertaining to nuclear medicine scans and its application in disease diagnosis and treatment validation?
- Which parameters are responsible for the market dominance of North America regional segment in radiation dose management market?
